Marlowe SPF 50
NDC 82215-0001, Avobenzone, Homosalate, Octisalate, Octocrylene, lotion, from Marlowe Holdings, LLC.
- Product NDC
- 82215-0001
- Status
- Listed
- Labeler
- Marlowe Holdings, LLC
- Dosage form
- LOTION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82215-0001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTOCRYLENE49.9 mg/mL
- AVOBENZONE29.94 mg/mL
- OCTISALATE49.9 mg/mL
- HOMOSALATE99.8 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82215-0001-3 | 82215000103 | 100 mL in 1 TUBE (82215-0001-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 82215-0001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82215-0001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82215-0001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.